CLDN2 and hepatocellular carcinoma: Recent studies show that SPIB is upregulated in certain solid malignancies including colon cancer, hepatocellular carcinoma and gastric cancer46 and increases invasive behaviour of lung cancer cells via downregulation of claudin‐2,47 indicating its involvement in tumourigenesis.